BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 12676738)

  • 1. Effect of Everolimus versus Bone Marrow-Derived Stem Cells on Glomerular Injury in a Rat Model of Glomerulonephritis: A Preventive, Predictive and Personalized Implication.
    Zedan MM; Mansour AK; Bakr AA; Sobh MA; Khodadadi H; Salles EL; Alhashim A; Baban B; Golubnitschaja O; Elmarakby AA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol consumption and all-cause and cause-specific mortality among US adults: prospective cohort study.
    Tian Y; Liu J; Zhao Y; Jiang N; Liu X; Zhao G; Wang X
    BMC Med; 2023 Jun; 21(1):208. PubMed ID: 37286970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic Acid Bacteria Isolated from Japanese Fermented Fish (Funa-Sushi) Inhibit Mesangial Proliferative Glomerulonephritis by Alcohol Intake with Stress.
    Yamada Y; Endou M; Morikawa S; Shima J; Komatshzaki N
    J Nutr Metab; 2018; 2018():6491907. PubMed ID: 29607219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation of central imidazoline I(1)-site/extracellular signal-regulated kinase/p38 mitogen-activated protein kinase signalling mediates the hypotensive effect of ethanol in rats with acute renal failure.
    El-Mas MM; El-Gowelli HM; Ghazal AR; Harraz OF; Mohy El-Din MM
    Br J Pharmacol; 2009 Nov; 158(6):1629-40. PubMed ID: 19845670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
    Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.
    Peters H; Daig U; Martini S; Rückert M; Schäper F; Liefeldt L; Krämer S; Neumayer HH
    Kidney Int; 2003 Aug; 64(2):509-18. PubMed ID: 12846746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
    Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis.
    Wan YG; Sun W; Zhen YJ; Che XY; Pu HP; Wang Y; Li M; Ruan JG; Yan QJ
    J Ethnopharmacol; 2011 Jun; 136(2):322-33. PubMed ID: 21570456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis.
    Peters H; Eisenberg R; Daig U; Liefeldt L; Westenfeld R; Gaedeke J; Krämer S; Neumayer HH
    Kidney Int; 2004 Jun; 65(6):2238-48. PubMed ID: 15149337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate alcohol intake has no impact on acute and chronic progressive anti-thy1 glomerulonephritis.
    Peters H; Martini S; Woydt R; Rückert M; Shimizu F; Kawachi H; Liefeldt L; Krämer S; Neumayer HH
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1105-14. PubMed ID: 12676738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephritic model induced by anti-Thy1.1 monoclonal antibody and its application to study on Chinese materia medica].
    Wan YG; Sun W; Zhang J; Li M; Ruan JG; Wang Y; Shmizu F
    Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(6):461-5. PubMed ID: 17552144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives in treatment of glomerulonephritis.
    Coppo R; Amore A
    Pediatr Nephrol; 2004 Mar; 19(3):256-65. PubMed ID: 14673633
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.